Trials / Unknown
UnknownNCT02908802
Probiotic Supplement as Treatment for Students With ADHD
A Double-Blind Placebo Controlled Study of Probiotic Supplement as Treatment for Students With Attention Deficit Hyperactivity Disorder (ADHD)
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 45 (estimated)
- Sponsor
- Tel Hai College · Academic / Other
- Sex
- All
- Age
- 19 Years – 30 Years
- Healthy volunteers
- Accepted
Summary
Subjects will answer the following questionnaire and tests: * Symptom severity and improvement will be measured using ADHA Rating scale IV (ADHD RS) * Demographic Questionnaire - composed by the researchers * Family Eating Habits Questionnaire (FEAHQ-33) * Food Frequency Questionnaire (FFQ) * Test MOXO The subjects will take the study product for six months. After six months the subject will fill once again all the questionnaires.
Detailed description
Computerized performance test MOXO - the test has been developed in Israel by Neurotech Company. The test's goal is to assess and define a participant's performance according to the four indices of Attention Deficit Hyperactivity Disorder: Attention, Hyperactivity, Impulsivity, and Timing with adjustment for age. Subjects will answer the following questionnaire and tests: * Symptom severity and improvement will be measured using ADHA Rating scale IV (ADHD RS) * Demographic Questionnaire - composed by the researchers * Family Eating Habits Questionnaire (FEAHQ-33) * Food Frequency Questionnaire (FFQ) * Test MOXO The subjects will take the study product for six months. After six months the subject will fill once again all the questionnaires.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Probiotic | Probiotic |
| DIETARY_SUPPLEMENT | Placebo | Probiotics capsules without the active ingredient |
Timeline
- Start date
- 2016-11-01
- Primary completion
- 2019-09-01
- Completion
- 2019-10-01
- First posted
- 2016-09-21
- Last updated
- 2018-09-12
Source: ClinicalTrials.gov record NCT02908802. Inclusion in this directory is not an endorsement.